Analyst Group Comment on STENOCARE’s Updated Guidance for 2024

STENOCARE announced on October 14th that the company has updated the sales guidance for 2024, from gross sales of DKK 6-8m, which are now expected to amount to DKK 4.5m. STENOCARE is also exploring various financing opportunities to meet both short-term and long-term capital needs.

Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-stenocares-updated-guidance-for-2024/